RxDoctor Payments Data

Dean Inouye, MD

Psychiatry · Alexandria, VANPI 1902874605

Payments from drug & device makers

$579in general payments, 2019–2025

Across 23 payments — averaging $25.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$219
  • Otsuka America Pharmaceutical, Inc.$110
  • Johnson & Johnson$68
  • Alkermes, Inc.$47
  • Vanda Pharmaceuticals Inc.$44
  • E.r. Squibb & Sons, L.L.C.$27
  • plus $64 from 3 others

What the payments were for

  • Food & beverage$45278%
  • Education$12722%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$579 in reported general payments places this provider in the 65th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia

Medicare billing

Part B allowed, 2024
$16,758
Medicare patients
28
Services billed
152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate41$105,366
Abilify MaintenaAripiprazole19$45,080
Aripiprazole73$9,321
Bupropion XlBupropion Hcl64$1,789
Olanzapine53$1,346
Quetiapine Fumarate55$957
Haloperidol Decanoate38$901
Divalproex Sodium11$575
Duloxetine Hcl33$569
Trazodone Hcl38$499
Fluvoxamine Maleate14$495
Mirtazapine28$485
Risperidone36$305
Escitalopram Oxalate50$269
Clonazepam39$263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$68$105,36641 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$110$45,08019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →